Chronic kidney disease has a variety of causes, ranging from immune system problems to medication side effects ...
A commentary by Calvin Meaney urges discontinuation of outdated tests that are imprecise or disadvantage Black patients.
Fabry disease is a rare, X-linked genetic lysosomal storage disorder caused by a deficient enzyme called alpha-galactosidase A. Without it, a fatty substance called globotriaosylceramide, or GL-3, ...
IgA nephropathy, an immune assault on the kidneys, is often missed. New treatments mean that spotting it sooner might save ...
R1 Therapeutics is debuting with an oversubscribed $77.5 million series A financing aimed at advancing its first-in-class ...
Bayer BAYRY announced that finerenone achieved the primary endpoint in the late-stage FIND-CKD study, marking a key milestone in expanding its use to patients with non-diabetic chronic kidney disease ...
Series A co-led by Abingworth, DaVita Venture Group, and F-Prime with participation from Curie.Bio, SymBiosis, and U.S. Renal CarePartnership with Alebund Pharmaceuticals to gain exclusive global ...
Company shares surged in after-market trading on results for a drug Vertex acquired in a multibillion-dollar deal and sees as ...
A Japanese registry has identified a blind spot in the routine care of patients with chronic kidney disease (CKD). Serum ...
THE Sustainable Health Education and Intervention Limited (SHEILD), a non-governmental organisation, has called for a stronger national commitment to tackling kidney disease through policy support, ...
A woman has described how her daughter managed to "beat the odds" time and time again after having kidney failure, a kidney ...